Global Schisandra Market - 2020-2027
|出版日期||内容资讯||英文 151 Pages
|全球五味子市场:2020～2027年 Global Schisandra Market - 2020-2027|
|出版日期: 2021年03月31日||内容资讯: 英文 151 Pages||
五味子(Schisandra Chinensis)，是深红的果实，长时间用于中药的植物。五味子在传统中药中被归类为 "适应原" ，是指透过平衡身体功能来帮助人体维持体内稳态的植物或草药。五味子浆果还具有强大的抗氧化保护作用，尤其是避免环境中的自由基与其他可能导致细胞损伤的毒素的侵害。 在中药(TCM)中，五味子被认为具有抗衰老特性以及增强身体，心理和性耐受力的能力。 浆果种子可用于治疗多种疾病，包括哮喘、咳嗽、消化不良、腹泻、流感、失眠、皮肤过敏、心悸、胰岛素抗性和经前综合症。由于这些优势，五味子市场，在预测期间内预计以7.56％的年复合成长率扩大。
Schisandra (Schisandra Chinensis) is a plant whose deep red berries have long been used in traditional Chinese medicine. Schisandra is classified as an "adaptogen" in traditional Chinese medicine, which refers to a plant or herb that helps the body maintain homeostasis by balancing its functions. Since it contains all five of the essential flavors of Chinese herbal medicine, the berry is sometimes referred to as the "five-flavor berry": sweet, salty, spicy, sour, and bitter. Schisandra berries also provide powerful antioxidant protection, particularly from free radicals and other toxins in the environment that may cause cellular damage. In Traditional Chinese Medicine (TCM), Schisandra is considered to have anti-aging properties as well as the ability to enhance physical, mental, and sexual endurance. The seeds of berries can be used to treat a number of illnesses, including asthma, cough, indigestion, diarrhea, flu, insomnia, skin allergies, heart palpitations, insulin resistance, and premenstrual syndrome. Due to these advantages, the market for Schisandra is expected to grow with a CAGR of 7.56% during the forecast period. Schisandra market value is likely to reach USD XX thousand in 2027, from its recorded value of USD XX thousand in 2019.
Schisandra is used to treat a variety of health problems. Schisandra can have a beneficial impact on a number of conditions and diseases, according to scientific evidence from animal and human studies. For instance, Schisandrin B have a beneficial, positive effect on Alzheimer's disease. Researchers discovered the positive effect was caused by Schisandrin B's ability to block formation of excess amyloid beta peptides in the brain. These peptides are one of the components that contribute to the formation of amyloid plaque, a material contained in Alzheimer's patients' brains. According to a study, Schisandrin B could be useful in the treatment of both Alzheimer's and Parkinson's disease. This is because it has an anti-inflammatory and neuroprotective effect on brain microglial cells. The effects of Schisandra extract on women suffering from menopausal symptoms were investigated in a 2016 study. For a year, 36 menopausal women were followed. Researchers discovered that Schisandra can help alleviate some of the symptoms of menopause. Schisandra also has adaptogenic properties which help the body resist the effects of anxiety and stress, and bolster the body's defenses against stress. Additionally, schisandra offers great benefits for athletes.
Pharmaceuticals segment is expected to be the largest segment with a share of XX% during the forecast period.
The Schisandra market, on the basis of application, is segmented into the pharmaceuticals, food & beverages and cosmetics among others. The pharmaceuticals segment held the largest share as of 2019, owing to the widespread use of Schisandra extract in Traditional Chinese Medicine (TCM). Rising interest towards herbal dietary supplements and rapidly growing utilization of Schisandra extracts in these formulations will also propel the growth of the market. Schisandra is widely used for pharmaceutical applications in countries such as China, Japan and South Korea. It is also used for treating liver disease (hepatitis) and protecting the liver from poisons. Some people use Schisandra to assist with breathing issues such as wheezing, coughing, or shortness of breath. Others believe it would aid the body in stress adaptation and disease prevention. Schisandra is also used to slow down the aging process and increase lifespan, as well as to normalize blood sugar and blood pressure, stimulate the immune system, and speed up recovery after surgery. Deoxyschizandrin, a major dibenzocyclooctadiene lignan in Schisandra berries, has also been suggested to enhance lung cancer cells' responsiveness to anti-cancer drugs.
Asia Pacific region accounted for the largest share of the global Schisandra market. China dominated the Asia Pacific Schisandra market with a share of XX% in the year 2019. In China, it is popular to include medicinal plants of various kinds in foods to improve their overall health benefits. Schisandra is widely used in the food and beverage applications. According to the Chinese, drinking Schisandra berry tea for one hundred days will repair health completely. Drinking Schisandra berry tea every day, at least twice a day, can help lose at least two pounds a week. Infusing Schisandra berries with dark cherry juice is one way to achieve the weight-loss benefits of doing so on a daily basis. Cherry juice is also a blood and liver fortifier that has been related to weight loss through metabolism control. The anti-inflammatory properties of the Schisandra berries can be improved by the Vitamin C in dark cherry juice. Moreover, presence of key players in China is expected to drive the China Schisandra market from USD XX thousand in 2019, to USD XX thousand in 2027, growing with a CAGR of 8.41% during the forecast period. Hunan Nuoz Biological Technology Co., Ltd, Shaanxi Fuheng (FH) Biotechnology Co., Ltd, Suzhou Vitajoy Bio Tech. Ltd and Xi'an SR Bio-Engineering Co., Ltd. some of the key players in China Schisandra market.
The global Schisandra extract market is fragmented, with a large number of small players operating in the market. As the production of Schisandra is highly consolidated in few countries such as China, South Korea, Japan and Russia, extract producing companies are also bounded to these regions. Most of the major companies are operating in China with limited direct sales in global markets. The distribution of Schisandra extract in other countries is covered by local herbs, herbal extracts and phytochemical suppliers. Hunan Nuoz Biological Technology Co., Ltd, Suzhou Vitajoy Bio Tech. Ltd, Shanghai Freemen, Shaanxi Fuheng (FH) Biotechnology Co., Ltd and Greenutra Resource Inc. are some of the key players operating the market. Most of these companies are framing agreements with herbal medicine, supplements, food and cosmetic manufacturers for the supply of their Schisandra extract as an ingredient. Furthermore, these companies are focused towards the integration of value chain by entering in to supplement or other end-use formulation, thereby gaining a wide customer base and business margins
COVID-19 Impact: The market revenue for global Schisandra to shoot up to USD XX thousand in 2020 from nearly USD XX thousand in 2019, due to the pandemic
Herbal ingredients made from wild plants in Traditional Chinese Medicine (TCM) and other herbal-based products around the world is expected to rise dramatically as a result of the COVID-19 outbreak. Plants account for roughly 80% of TCM products in China. Wild plant species account for approximately 30% of TCM industrial production volume, accounting for 70% of the species. The TCM industry's resource base is made up of supply chains from China and around the world. COVID-19 patients in China are treated with a mixture of TCM and Western treatments, with official COVID-19 drug variants provided by the National Health Commission of the People's Republic of China. A study that screened 125 Chinese herbal medicines with the potential to directly inhibit COVID-19, as well as an analysis of historical records and human proof of SARS and H1N1 influenza prevention, are examples of research into the effectiveness of herbal treatments for COVID-19. Dried Schisandra berries, is one of the most frequently used plant species for SARS treatment.